1679 related articles for article (PubMed ID: 27832845)
21. Impact of Aortomitral Continuity Calcification on Need for Permanent Pacemaker After Transcatheter Aortic Valve Replacement.
Katchi F; Bhatt D; Markowitz SM; Szymonifka J; Cheng EP; Minutello RM; Bergman GW; Wong SC; Salemi A; Truong QA
Circ Cardiovasc Imaging; 2019 Dec; 12(12):e009570. PubMed ID: 31813271
[TBL] [Abstract][Full Text] [Related]
22. Predictors of paravalvular regurgitation and permanent pacemaker implantation after TAVR with a next-generation self-expanding device.
Mauri V; Deuschl F; Frohn T; Schofer N; Linder M; Kuhn E; Schaefer A; Rudolph V; Madershahian N; Conradi L; Rudolph TK; Schäfer U
Clin Res Cardiol; 2018 Aug; 107(8):688-697. PubMed ID: 29667013
[TBL] [Abstract][Full Text] [Related]
23. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
24. Low permanent pacemaker rates following Lotus device implantation for transcatheter aortic valve replacement due to modified implantation protocol.
Krackhardt F; Kherad B; Krisper M; Pieske B; Laule M; Tschöpe C
Cardiol J; 2017; 24(3):250-258. PubMed ID: 28248410
[TBL] [Abstract][Full Text] [Related]
25. Predictors of permanent pacemaker insertion after TAVR: A systematic review and updated meta-analysis.
Mahajan S; Gupta R; Malik AH; Mahajan P; Aedma SK; Aronow WS; Mehta SS; Lakkireddy DR
J Cardiovasc Electrophysiol; 2021 May; 32(5):1411-1420. PubMed ID: 33682218
[TBL] [Abstract][Full Text] [Related]
26. Predictors for new-onset conduction block in patients with pure native aortic regurgitation after transcatheter aortic valve replacement with a new-generation self-expanding valve (VitaFlow Liberty
Zhang X; Liang C; Zha L; Zuo Q; Hu G; Ding J; Tang S
BMC Cardiovasc Disord; 2024 Jan; 24(1):77. PubMed ID: 38281925
[TBL] [Abstract][Full Text] [Related]
27. Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.
Rampat R; Khawaja MZ; Hilling-Smith R; Byrne J; MacCarthy P; Blackman DJ; Krishnamurthy A; Gunarathne A; Kovac J; Banning A; Kharbanda R; Firoozi S; Brecker S; Redwood S; Bapat V; Mullen M; Aggarwal S; Manoharan G; Spence MS; Khogali S; Dooley M; Cockburn J; de Belder A; Trivedi U; Hildick-Smith D
JACC Cardiovasc Interv; 2017 Jun; 10(12):1247-1253. PubMed ID: 28641846
[TBL] [Abstract][Full Text] [Related]
28. Predictors for the risk of permanent pacemaker implantation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
Wang T; Ou A; Xia P; Tian J; Wang H; Cheng Z
J Card Surg; 2022 Feb; 37(2):377-405. PubMed ID: 34775652
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesis.
Droppa M; Rudolph TK; Baan J; Nielsen NE; Baumgartner H; Vendrik J; Froehlich M; Borst O; Wöhrle J; Gawaz M; Potratz P; Hack LP; Mauri V; Baranowski J; Bramlage P; Kurucova J; Thoenes M; Rottbauer W; Geisler T
Heart Vessels; 2020 Dec; 35(12):1735-1745. PubMed ID: 32591894
[TBL] [Abstract][Full Text] [Related]
30. Calcium distribution patterns of the aortic valve as a risk factor for the need of permanent pacemaker implantation after transcatheter aortic valve implantation.
Fujita B; Kütting M; Seiffert M; Scholtz S; Egron S; Prashovikj E; Börgermann J; Schäfer T; Scholtz W; Preuss R; Gummert J; Steinseifer U; Ensminger SM
Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(12):1385-1393. PubMed ID: 26758411
[TBL] [Abstract][Full Text] [Related]
31. Transcatheter Heart Valve Selection and Permanent Pacemaker Implantation in Patients With Pre-Existent Right Bundle Branch Block.
van Gils L; Tchetche D; Lhermusier T; Abawi M; Dumonteil N; Rodriguez Olivares R; Molina-Martin de Nicolas J; Stella PR; Carrié D; De Jaegere PP; Van Mieghem NM
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28258051
[TBL] [Abstract][Full Text] [Related]
32. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
[TBL] [Abstract][Full Text] [Related]
33. Timing of Onset and Outcome of New Conduction Abnormalities Following Transcatheter Aortic Valve Implantation: Role of Balloon Aortic Valvuloplasty.
Campelo-Parada F; Nombela-Franco L; Urena M; Regueiro A; Jiménez-Quevedo P; Del Trigo M; Chamandi C; Rodríguez-Gabella T; Auffret V; Abdul-Jawad Altisent O; DeLarochellière R; Paradis JM; Dumont E; Philippon F; Pérez-Castellano N; Puri R; Macaya C; Rodés-Cabau J
Rev Esp Cardiol (Engl Ed); 2018 Mar; 71(3):162-169. PubMed ID: 28566243
[TBL] [Abstract][Full Text] [Related]
34. Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
Alasti M; Rashid H; Rangasamy K; Kotschet E; Adam D; Alison J; Gooley R; Zaman S
Catheter Cardiovasc Interv; 2018 Oct; 92(4):777-782. PubMed ID: 29314625
[TBL] [Abstract][Full Text] [Related]
35. Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve.
Tang GHL; Zaid S; George I; Khalique OK; Abramowitz Y; Maeno Y; Makkar RR; Jilaihawi H; Kamioka N; Thourani VH; Babaliaros V; Webb JG; Htun NM; Attinger-Toller A; Ahmad H; Kaple R; Sharma K; Kozina JA; Kaneko T; Shah P; Hirji SA; Desai ND; Anwaruddin S; Jagasia D; Herrmann HC; Basra SS; Szerlip MA; Mack MJ; Mathur M; Tan CW; Don CW; Sharma R; Gafoor S; Zhang M; Kapadia SR; Mick SL; Krishnaswamy A; Amoroso N; Salemi A; Wong SC; Kini AS; Rodés-Cabau J; Leon MB; Kodali SK
JACC Cardiovasc Interv; 2018 Jul; 11(14):1377-1387. PubMed ID: 29960755
[TBL] [Abstract][Full Text] [Related]
36. Aortic valve and left ventricular outflow tract calcium volume and distribution in transcatheter aortic valve replacement: Influence on the risk of significant paravalvular regurgitation.
Hansson NC; Leipsic J; Pugliese F; Andersen HR; Rossi A; Simonato M; Jensen KT; Christiansen EH; Terkelsen CJ; Blanke P; Tang M; Krusell LR; Klaaborg KE; Terp K; Kennon S; Dvir D; Bøtker HE; Webb J; Nørgaard BL
J Cardiovasc Comput Tomogr; 2018; 12(4):290-297. PubMed ID: 29519754
[TBL] [Abstract][Full Text] [Related]
37. Conduction Disturbances and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: Predictors and Prevention.
Tsoi M; Tandon K; Zimetbaum PJ; Frishman WH
Cardiol Rev; 2022 Jul-Aug 01; 30(4):179-187. PubMed ID: 34132653
[TBL] [Abstract][Full Text] [Related]
38. Incidence, indications and predicting factors of permanent pacemaker implantation after transcatheter aortic valve implantation: A retrospective study.
Becker M; Blangy H; Folliguet T; Villemin T; Freysz L; Luc A; Maureira P; Popovic B; Olivier A; Sadoul N
Arch Cardiovasc Dis; 2017 Oct; 110(10):508-516. PubMed ID: 28647466
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of Direct Transcatheter Aortic Valve Replacement Without Balloon Aortic Valvuloplasty Using a New Generation Valve.
Aalaei-Andabili SH; Beaver TM; Bavry AA; Petersen JW; Karimi A; Wayangankar S; Arnaoutakis G; Anderson RD
Cardiovasc Revasc Med; 2019 Dec; 20(12):1100-1104. PubMed ID: 30826204
[TBL] [Abstract][Full Text] [Related]
40. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
